In Brief: FDA Division of Reproductive & Urological Drug Products
Executive Summary
FDA Division of Reproductive & Urological Drug Products: New division under the Office of Drug Evaluation II will be headed by Lisa Rarick, MD. Rarick has been a medical officer in the Division of Metabolic & Endocrine Drug Products, which has been responsible for reproductive drugs...